As we approach the end of 2024, we at Goddess Gaia Ventures want to take a moment to look back on what has been an extraordinary year for women’s health—a year marked by progress, collaboration, and innovation.
This year, while not without its challenges, has brought remarkable breakthroughs:
💡 Raising Awareness
Women’s health is no longer a niche conversation—it’s front and center:
• In January, McKinsey & Company’s groundbreaking report highlighted untapped opportunities in women’s health.
• Melinda French Gates announced a transformative $250M investment in this space.
• The White House committed $12 billion to women’s health research, an unprecedented move.
🌍 Scaling Solutions
Innovative startups and leaders are driving tangible change:
• Maven Clinic was valued at $1.7 billion and Flo Health Inc. reached unicorn status following their Series C funding, underscoring the growing value of women’s health tech.
• Rock Health reported that 38% of new healthcare investments this year went into AI-enabled technologies, setting the stage for smarter, more accessible solutions.
💰 Growing Investments
The market has seen unprecedented growth, fueling innovation and change:
• Dealroom.co valued femtech companies at an impressive $28 billion in 2024.
• Bessemer Venture Partners noted a rebound in healthtech VC investments, returning to pre-COVID levels.
At GGV, 2024 has been a transformative year. We’ve expanded our focus to include emerging verticals such as AI, Longevity, and Sports—building on our commitment to driving impactful innovation.
It’s a privilege to stand alongside trailblazing founders, investors, and advocates who share our vision for a healthier, more equitable world.
💜 From all of us at Goddess Gaia Ventures, we wish you Happy Holidays and a wonderful New Year!
Together, let’s continue to make history in 2025.
Warmly,
GGV Team
